Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (study rindo)
FOLFIRI方案联合低剂量伊立替康加雷莫芦单抗作为二线治疗方案治疗日本转移性结直肠癌患者的II期研究(rindo研究)
期刊:Japanese Journal of Clinical Oncology
影响因子:2.2
doi:10.1093/jjco/hyaf198
Hattori, Norifumi; Nakayama, Goro; Umeda, Shinichi; Kishida, Takayoshi; Takeda, Shigeomi; Ezaka, Kazuhiro; Tsutsuyama, Masayuki; Sakai, Mitsuru; Hattori, Masashi; Ito, Takeshi; Kanda, Mitsuro; Tanaka, Chie; Murotani, Kenta; Ando, Masahiko; Kodera, Yasuhiro